Put simply, stem cells are not magical repair crews – they’re living entities, just like all other cells in the body. These smallest units of life behave similarly to the whole: like us, they need the right nutrients, they move, age, and become exhausted. Some cells prefer the company of others, while some can function just fine on their own. And function they must – stem cells and body cells alike are constantly working to keep us alive and well. What makes a stem cell special is its ability to choose its “career path”: will it one day become bone, cartilage, or muscle? Many paths are possible – but only when the conditions are right.

How stem cells behave depends on various factors: their health, their environment, and how they’re used. A stem cell injected uncharacterised and randomly into a joint capsule won’t be able to repair a specific defect in the cartilage. Overpromising results like these harm the field as a whole. Costly treatments that involve injecting stem cells into damaged tissue often lead to disappointment: pain persists, and the hoped-for regeneration doesn’t occur. Stem cells are powerful – but not all-powerful. They require precise guidance, the right tools, and most importantly, they must be healthy themselves.

Stem Cell Source: Fat Tissue

When people hear “stem cells,” they often think of embryos or cord blood. Indeed, the so-called pluripotent stem cells – those that can become any cell type – exist only in the earliest stages of development. But even after the “all-rounders,” there remain stem cells that are still highly capable: adult stem cells, harvested from mature tissue.

One particularly promising approach involves using stem cells derived from fat tissue. These so-called adipose-derived stem cells are easily accessible and available in large quantities, making them ideal for autologous (patient-derived) therapies. They can differentiate into cells that help build soft tissue, bone, or cartilage, repairing damage, reducing inflammation, and supporting healing. However, not all fat stem cells perform equally well. Like all living cells, they have good days and bad, and their regenerative capacity can be influenced by factors such as the donor’s age, genetic background, or health conditions.

Dr. Marlene Wahlmüller, a researcher at the Ludwig Boltzmann Institute for Traumatology (LBI Trauma), the research center in cooperation with AUVA, works in the Cell-Based Therapies group led by Dr. Susanne Wolbank. Her research explores the regenerative potential of adipose-derived stem cells, including those taken from patients with lipedema.

Lipedema is a chronic fat tissue disorder that primarily affects women, leading to abnormal fat accumulation, particularly in the legs and hips. Though current estimates suggest up to 10% of women may be affected (it is extremely rare in men), the condition is often misunderstood and misdiagnosed. In early stages, symptoms resemble obesity, and many patients are simply told to lose weight – often without success, since diet and exercise do not reduce the diseased fat tissue. Remarks like “She just has thick legs” are all too common, despite lipedema being a serious and extremely painful fat tissue disorder. It typically appears symmetrically on the legs, arms, and hips and is often accompanied by heaviness, sensitivity to pressure, and a tendency to bruise easily.
Recent research from the group showed that adipose-derived stem cells in lipedema tissue are not only affected by the disease; they may even play an active role in its progression.

New strategies to optimise stem cell therapy

In her PhD project, completed at the LBI Trauma branch in Linz, Dr. Wahlmüller explored several ways to improve the function of adipose-derived stem cells.

She found that fat tissue often contains so-called senescent cells, which release inflammatory signals and can impair the regenerative function of other cells. Using specific drugs to counteract this state, she was able to show that the regenerative quality of cell samples significantly improved. This could help enhance the effectiveness of stem cell therapies in older patients or those with pre-existing conditions.

Additionally, Dr. Wahlmüller worked on a method to stimulate exhausted cells using biophysical cues. In a 3D microfluidic platform, adipose-derived stem cells were treated with shockwave stimulation. The result: improved cell function and vitality, including increased ATP release and greater ability to differentiate. These innovative strategies could lay the foundation for more effective regenerative treatments.

Research on fat-derived stem cells is much more than a glimpse into the future – it shows that we’re already working today to make regenerative medicine more reliable and effective. And it’s a reminder that even “miracle cells” need a careful hand to truly unlock their potential.